Select Publications
Journal articles
2005, 'Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC)', Journal of Clinical Oncology, 23, pp. 3581 - 3581, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.3581
,2005, 'Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients', British Journal of Cancer, 92, pp. 832 - 837, http://dx.doi.org/10.1038/sj.bjc.6602426
,2005, 'Fertility - and Menoapuse-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer', Journal of Clinical Oncology, 23, pp. 5155 - 5165
,2005, 'Gastrointestinal Stromal Tumours: Correlation of 18F-FDG Gamma Camera-Based Coincidence Positron Emission tomography with CT for the Assessment of Treatment Response - An AGITG Study', Oncology, 69, pp. 326 - 332
,2005, 'Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A Eurpoean Organisation for Research and Treatment of Cancer etc.', Journal of Clinical Oncology, 23, pp. 5795 - 5804
,2005, 'Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines', Cancer Letters, 225, pp. 61 - 74
,2005, 'Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience', Internal Medicine Journal, 35, pp. 34 - 38
,2005, 'Oxaliplatin-induced neurotoxicity and the development of neuropathy', Muscle and Nerve, 32, pp. 51 - 60
,2005, 'Promising results of a cooperative group phase II trial of preoperative chemoradiation For locally advanced rectal cancer (TROG 9801)', Diseases of the Colon and Rectum, 48, pp. 1389 - 1396
,2005, 'Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour', Lancet Oncology, 6, pp. 724 - 727
,2005, 'Selective Internal Radiation Therapy (SIRT) plus systemic chemotherapy with Irinotecan. A phase I dose escalation study', Journal of Clinical Oncology, 23, pp. 3701 - 3701, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.3701
,2005, 'The role of chemotherapy in the treatment of pancreatic carcinoma', Australian Prescriber, 28, pp. 42 - 44
,2005, 'Understanding community beliefs of Chinese-Australians about cancer: Initial insights using an ethnographic approach', Psycho - Oncology, 14, pp. 174 - 186
,2004, 'Education and role modelling for clinical decisions with female cancer patients', Health Expectations, 7, pp. 303 - 316, http://dx.doi.org/10.1111/j.1369-7625.2004.00294.x
,2004, 'Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: An Australian multicentre experience', ANZ Journal of Surgery, 74, pp. 951 - 956, http://dx.doi.org/10.1111/j.1445-1433.2004.03218.x
,2004, 'Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report', BMC Cancer, 4, pp. 74, http://dx.doi.org/10.1186/1471-2407-4-74
,2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy', Journal of Clinical Oncology, 22, pp. 4100 - 4100, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.4100
,2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy.', J Clin Oncol, 22, pp. 4100, http://www.ncbi.nlm.nih.gov/pubmed/28014508
,2004, 'Blood level of phosphoglycerate kinase does not correlate with presenceor extent of tumor', International Journal of Biological Markers, 19, pp. 170 - 172
,2004, 'Cancer Patient Preferences for Communication of Prognosis in the Metastatic Setting', Journal of Clinical Oncology, 22, pp. 1721 - 1730
,2004, 'Castleman`s disease and HIV infection in Australia', HIV Medicine, 5, pp. 157 - 162
,2004, 'Change in epidermal growth factor receptor expression in human bladdercancer cell lines following interferon-alpha treatment', Journal of Urology, 172, pp. 733 - 738
,2004, 'Clinical features and predictors of survival of AIDS-related non-Hodgkin`s lymphoma in a population-based case series in Sydney, Australia', HIV Medicine, 5, pp. 377 - 384
,2004, 'Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells', Pancreas, 29, pp. 179 - 187
,2004, 'Fatigue and psychological distress - exploring the relationship in women treated for breast cancer', European Journal of Cancer, 40, pp. 1689 - 1695
,2004, 'Modern management of pancreatic cancer', Internal Medicine Journal, 34, pp. 475 - 481
,2004, 'Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha', Gut, 53, pp. 123 - 129
,2004, 'Remoteness of residence and survival from cancer in New South Wales', Medical Journal of Australia, 180, pp. 618 - 622
,2003, 'Is improving local control sufficient indication for radiotherapy in the management of rectal cancer? A response [1] (multiple letters)', ANZ Journal of Surgery, 73, pp. 660 - 661, http://dx.doi.org/10.1046/j.1445-2197.2003.t01-1-02719.x
,2003, 'Cicatricial pemphigoid in non-Hodgkin`s lymphoma', Internal Medicine Journal, 33, pp. 396 - 397
,2003, 'Delayed relapse following preoperative chemoradiation and surgery for rectal cancer', International Journal of Radiation Oncology*Biology*Physics, 57, pp. S220 - S220, http://dx.doi.org/10.1016/s0360-3016(03)01035-6
,2003, 'Multicentric Castleman's Disease Treated with Antivirals and Immunosuppressants', Journal of Medical Virology, 71, pp. 399 - 403
,2003, 'Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians', Social Science and Medicine, 59, pp. 235 - 248
,2002, 'α-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, 32, pp. 158 - 162, http://dx.doi.org/10.1046/j.1444-0903.2001.00184.x
,2002, 'Alpha-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, 32, pp. 158 - 162
,2002, 'Communicating in a multicultural society II: Greek community attitudes towards cancer in Australia', Internal Medicine Journal, 32, pp. 289 - 296
,2002, 'Elevated alpha-foetoprotein and hepatic metastases - it`s not always what it seems!', Annals of Oncology, 13, pp. 167 - 169
,2002, 'Prolonged survival in a patient with an occult small-cell lung cancer and a solitary brain metastasis at diagnosis', Internal Medicine Journal, 32, pp. 621 - 622
,2001, 'Cancer in the bush - Optimising clinical services', Cancer Forum, 25, pp. 121 - 125
,2001, 'Cultural aspects of cancer genetics: setting a research agenda', Journal of Medical Genetics, pp. 425 - 429
,2001, 'Early Toxicity from Preoperative Radiotherapy with Continuous Infusion 5-Fluorouracil for Resectable Adenocarcinoma of the Rectum: A Phase II Trial for the Trans-Tasman Radiation', International Journal of Radiation Oncology and Biology Physics, pp. 883 - 887
,2001, 'Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer', Lung Cancer, pp. 89 - 94
,2000, 'Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: Case report and review of the literature', Annals of Oncology, 11, pp. 1343 - 1347, http://dx.doi.org/10.1023/A:1008387800525
,2000, 'A phase II trial of preoperative radiotherapy with protracted infusion 5-fluorouracil for resectable adenocarcinoma of rectum. A multi-center trial for the Trans-Tasman Radiation Oncology Group', International Journal of Radiation Oncology*Biology*Physics, 48, pp. 119 - 120, http://dx.doi.org/10.1016/s0360-3016(00)80035-8
,1999, 'Attitudes and information needs of Chinese migrant cancer patients and their relatives', Australian and New Zealand Journal of Medicine, 29, pp. 207 - 213, http://dx.doi.org/10.1111/j.1445-5994.1999.tb00685.x
,1999, 'Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer', Journal of Clinical Oncology, 17, pp. 2355 - 2364, http://dx.doi.org/10.1200/jco.1999.17.8.2355
,1998, 'Long term follow-up of CEOP in the treatment of HIV related non- Hodgkin's lymphoma (NHL)', Australian and New Zealand Journal of Medicine, 28, pp. 28 - 32, http://dx.doi.org/10.1111/j.1445-5994.1998.tb04455.x
,1998, 'A phase 2 study of liposomal doxorubicin in the treatment of AIDS-related Kaposi¿s sarcoma', Australian and New Zealand Journal of Medicine, pp. 777 - 783
,1998, 'Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification', Journal of Infectious Diseases, 178, pp. 856 - 861
,1997, 'Paclitaxel as first-line treatment for metastatic breast cancer', ONCOLOGY, 11, pp. 19 - 23
,